{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CNY", "exchange": "SHZ", "shortName": "XINXIANG TUOXIN PH", "longName": "Xinxiang Tuoxin Pharmaceutical Co.,Ltd.", "messageBoardId": "finmb_109693427", "exchangeTimezoneName": "Asia/Shanghai", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "cn_market", "esgPopulated": false, "regularMarketChangePercent": 3.3171058, "regularMarketPrice": 80.67, "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.5054561, "fiftyTwoWeekLow": 52.53, "fiftyTwoWeekHigh": 163.12, "trailingAnnualDividendRate": 0.0, "trailingPE": 18.087444, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 4.46, "sharesOutstanding": 126000000, "bookValue": 9.471, "fiftyDayAverage": 63.0494, "fiftyDayAverageChange": 17.620598, "fiftyDayAverageChangePercent": 0.2794729, "twoHundredDayAverage": 79.2988, "twoHundredDayAverageChange": 1.3712006, "twoHundredDayAverageChangePercent": 0.017291568, "marketCap": 10164419584, "priceToBook": 8.51758, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 2.5899963, "regularMarketTime": 1683875086, "regularMarketDayHigh": 84.68, "regularMarketDayRange": "77.83 - 84.68", "regularMarketDayLow": 77.83, "regularMarketVolume": 10658736, "regularMarketPreviousClose": 78.08, "bid": 80.52, "ask": 80.54, "fullExchangeName": "Shenzhen", "financialCurrency": "CNY", "regularMarketOpen": 77.84, "averageDailyVolume3Month": 3808416, "averageDailyVolume10Day": 12060018, "fiftyTwoWeekLowChange": 28.14, "fiftyTwoWeekLowChangePercent": 0.5356939, "fiftyTwoWeekRange": "52.53 - 163.12", "fiftyTwoWeekHighChange": -82.45, "firstTradeDateMilliseconds": 1635298200000, "symbol": "301089.SZ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 515, Kelong Avenue", "address2": "Hongqi District", "city": "Xinxiang", "zip": "453000", "country": "China", "phone": "86 37 3635 1918", "fax": "86 37 3635 1919", "website": "https://www.tuoxinpharm.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Xinxiang Tuoxin Pharmaceutical Co.,Ltd. engages in the research, development, production, and sale of chemical synthesis, biological fermentation nucleoside (acid) APIs, and pharmaceutical intermediates in China and internationally. It offers purine base, pyrimidine base, nucleosides, nucleotide, deoxynucleosides, dehyfrated nucleoside, 2'-modified, Cybinucleoside, and sugar series, and Azvudine intermediate. The company also provides Disodium 5'-cytidylate, Disodium 5'-uridylate, 5'-Adenosine monophosphate, and D-ribose, as well as citicoline sodium, ribavir Lin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, and other APIs and pharmaceutical intermediates. The company was founded in 2001 and is based in Xinxiang, China.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Yuying  Cai", "age": 59, "title": "GM & Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Xiuqiang  Wang", "age": 52, "title": "Deputy GM & Director", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yehai  Yan", "age": 49, "title": "Deputy GM & Sec. of the Board", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}